Loading clinical trials...

COMPLETEDPhase 1NCT04725877

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

This is a Phase 1a, first in human study in which healthy adult participants who are considered to be at low-risk for HIV infection and are seropositive for cytomegalovirus (CMV) will receive two dose...

Lead sponsor: Vir Biotechnology, Inc.•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 2

Evaluating the Safety and Immunogenicity of MTBVAC

NCT05947890 · HIV I Infection, Tuberculosis

RECRUITINGNA

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

NCT06834113 · HIV I Infection, Injection Pain

RECRUITINGPhase 2

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

NCT05590455 · Tuberculous Meningitis, HIV I Infection

COMPLETEDNA

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa

NCT06214910 · Tuberculosis, HIV I Infection

COMPLETEDPhase 3

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

NCT05601128 · HIV-1-infection, HIV Infections, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 27, 2023Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment27

Start dateDec 2020

Last updatedFeb 27, 2023

Condition

HIV I Infection

Locations shown

Investigative Site

Miami, Florida

Investigative Site

Seattle, Washington

Investigative Site

Madison, Wisconsin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 27, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Evaluating the Safety and Immunogenicity of MTBVAC

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa

A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA

Trial snapshot

Condition

Locations shown

For caregivers